Heron Therapeutics Inc (HRTX) 財務データ
*すべての数値は百万単位です
| 期間終了日 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|---|
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues | 6.41%35.25 | 37.67 | 34.71 | 40.59 | 38.21 |
| Cost Of Revenue | 22.59%8.96 | 11.57 | 10.64 | 11.12 | 11.91 |
| Gross Profit | 0.76%26.29 | 26.09 | 24.07 | 29.47 | 26.30 |
14.69%3.10 | 2.70 | 2.39 | - | - | |
| Research and Development | 14.69%3.10 | 2.70 | 2.39 | - | - |
| Costs And Expenses | 0.63%27.96 | 28.14 | 28.84 | 29.43 | 30.39 |
| Operating Income/Loss | 18.35%-1.67 | -2.04 | -4.77 | 0.04 | -4.09 |
8.80%-5.01 | -5.49 | -8.11 | -2.95 | -17.50 | |
| Attributable To Parent | 8.80%-5.01 | -5.49 | -8.11 | -2.95 | -17.50 |
| Basic Average Shares | 0.31%190.92 | 190.34 | 189.65 | 7.18 | 170.35 |
| Diluted Average Shares | 0.31%190.92 | 190.34 | 189.65 | 7.18 | 170.35 |
| Basic Earnings Per Share | -0.03 | -0.03 | -0.04 | -0.01 | -0.10 |
| Diluted Earnings Per Share | -0.03 | -0.03 | -0.04 | -0.01 | -0.10 |